Carisma Therapeutics presents data at the AACR Tumor immunology and immunotherapy meeting 2019

November 18, 2019

Carisma Therapeutics Senior Scientist Konrad Gabrusiewicz, PhD, will present an abstract titled “CT-0508, a novel CAR macrophage product directed against HER2, promotes a pro-inflammatory tumor microenvironment” at the AACR Tumor Immunology and Immunotherapy 2019 meeting taking place November 17-20 in Boston, MA. For full conference agenda, see here.